{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:14:36Z","timestamp":1788408876742,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01CA266004"],"award-info":[{"award-number":["R01CA266004"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01HD052682"],"award-info":[{"award-number":["R01HD052682"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K01AR066077"],"award-info":[{"award-number":["K01AR066077"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AG066653"],"award-info":[{"award-number":["R01AG066653"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AG078702"],"award-info":[{"award-number":["R01AG078702"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["RM1NS133593"],"award-info":[{"award-number":["RM1NS133593"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymthe.2025.06.022","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T11:04:09Z","timestamp":1749899049000},"page":"4276-4289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5013-5972","authenticated-orcid":false,"given":"David D.","family":"Fuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabhya","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajwal P.","family":"Thakre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan S.","family":"Benevides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan K.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian G.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria N.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Vaught","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto A.","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reece C.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon C.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin J.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.06.022_bib1","article-title":"An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion","volume":"11","author":"Colburn","year":"2023","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymthe.2025.06.022_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2025.06.022_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe Disease: From Basic Science to Therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2025.06.022_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1152\/jn.00190.2021","article-title":"Case Studies in Neuroscience: Neuropathology and diaphragm dysfunction in ventilatory failure from late-onset Pompe disease","volume":"126","author":"Fuller","year":"2021","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/physiolgenomics.00075.2016","article-title":"Transcriptome assessment of the Pompe (Gaa-\/-) mouse spinal cord indicates widespread neuropathology","volume":"48","author":"Turner","year":"2016","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ymthe.2025.06.022_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.resp.2016.02.007","article-title":"Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-\/-)) mice","volume":"227","author":"Turner","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib8","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.06.022_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ene.13835","article-title":"Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis","volume":"26","author":"Musumeci","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.resp.2015.11.013","article-title":"Altered activation of the diaphragm in late-onset Pompe disease","volume":"222","author":"Smith","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nmd.2019.03.008","article-title":"Central drive and ventilatory failure in late-onset Pompe disease: At the gates of a new phenotype","volume":"29","author":"De Vito","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.06.022_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.nmd.2016.12.015","article-title":"Blunted respiratory drive response in late onset Pompe disease","volume":"27","author":"Monteiro","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.06.022_bib13","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4187\/respcare.03940","article-title":"Blunted Hypercapnic Respiratory Drive Response in Subjects With Late-Onset Pompe Disease","volume":"61","author":"De Vito","year":"2016","journal-title":"Respir. Care"},{"key":"10.1016\/j.ymthe.2025.06.022_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/humc.2017.146","article-title":"Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease","volume":"28","author":"Corti","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.022_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/hum.2012.250","article-title":"Phase I\/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes","volume":"24","author":"Smith","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib16","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/mt.2013.96","article-title":"Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease","volume":"21","author":"Falk","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/mt.2013.282","article-title":"Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice","volume":"22","author":"Elmallah","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/hum.2018.016","article-title":"Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease","volume":"30","author":"Keeler","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/WCO.0000000000001187","article-title":"Current avenues of gene therapy in Pompe disease","volume":"36","author":"Leon-Astudillo","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.7","article-title":"Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice","volume":"2","author":"Falk","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.022_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/hum.2018.020","article-title":"AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome","volume":"30","author":"Suzuki-Hatano","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-0556-6-13","article-title":"Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice","volume":"6","author":"Pacak","year":"2008","journal-title":"Genet. Vaccin. Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100304","article-title":"Regional N-glycan and lipid analysis from tissues using MALDI-mass spectrometry imaging","volume":"2","author":"Stanback","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ymthe.2025.06.022_bib24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.tem.2021.09.006","article-title":"Emerging roles of N-linked glycosylation in brain physiology and disorders","volume":"32","author":"Conroy","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.06.022_bib25","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cmet.2021.05.003","article-title":"Brain glycogen serves as a critical glucosamine cache required for protein glycosylation","volume":"33","author":"Sun","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.06.022_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216029","article-title":"In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues","volume":"14","author":"Young","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.06.022_bib27","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41467-023-38437-1","article-title":"Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis","volume":"14","author":"Conroy","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.022_bib28","article-title":"Spatial Metabolome Lipidome and Glycome from a Single brain Section","author":"Harrison","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.06.022_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/hum.2021.252","article-title":"Minimum Effective Dose to Achieve Biochemical Correction with Adeno-Associated Virus Vector-Mediated Gene Therapy in Mice with Pompe Disease","volume":"33","author":"Han","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JND-190426","article-title":"Advancements in AAV-mediated Gene Therapy for Pompe Disease","volume":"7","author":"Salabarria","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2025.06.022_bib31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/14712598.2022.2067476","article-title":"What's new and what's next for gene therapy in Pompe disease?","volume":"22","author":"Roger","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2147\/TCRM.S362871","article-title":"Monitoring and Management of Respiratory Function in Pompe Disease: Current Perspectives","volume":"19","author":"El Haddad","year":"2023","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ymthe.2025.06.022_bib33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2025.06.022_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mt.6300100","article-title":"Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors","volume":"15","author":"Mah","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib35","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.06.022_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101899","article-title":"Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy","volume":"81","author":"Munoz","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymthe.2025.06.022_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/humc.2014.2514","article-title":"Phase I\/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease","volume":"25","author":"Byrne","year":"2014","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.022_bib39","article-title":"Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease","volume":"3","author":"Prosser","year":"2018","journal-title":"MDM Policy Pract."},{"key":"10.1016\/j.ymthe.2025.06.022_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2025.06.022_bib41","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1542\/peds.2016-0280B","article-title":"Introduction to the Newborn Screening, Diagnosis, and Treatment for Pompe Disease Guidance Supplement","volume":"140","author":"Kishnani","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2025.06.022_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.omtm.2019.08.009","article-title":"AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice","volume":"15","author":"Doyle","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.022_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm.2019.04.49","article-title":"An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond","volume":"7","author":"Korlimarla","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.06.022_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/mt.2011.214","article-title":"Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice","volume":"20","author":"Qiu","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.022_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1540\/jsmr.57.8","article-title":"Glycogen accumulation in smooth muscle of a Pompe disease mouse model","volume":"57","author":"McCall","year":"2021","journal-title":"J. Smooth Muscle Res."},{"key":"10.1016\/j.ymthe.2025.06.022_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1126\/science.1172447","article-title":"Knockout rats via embryo microinjection of zinc-finger nucleases","volume":"325","author":"Geurts","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.06.022_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-60327-389-3_15","article-title":"Generation of gene-specific mutated rats using zinc-finger nucleases","volume":"597","author":"Geurts","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib48","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/en.2013-2150","article-title":"Generation of Esr1-knockout rats using zinc finger nuclease-mediated genome editing","volume":"155","author":"Rumi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymthe.2025.06.022_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11248-005-5077-z","article-title":"Transgenic modifications of the rat genome","volume":"14","author":"Tesson","year":"2005","journal-title":"Transgenic Res."},{"key":"10.1016\/j.ymthe.2025.06.022_bib50","first-page":"1431","article-title":"The laboratory rat: Age and body weight matter","volume":"20","author":"Ghasemi","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.ymthe.2025.06.022_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","article-title":"Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease","volume":"104","author":"van der Beek","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.06.022_bib52","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2025.06.022_bib53","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1089\/neu.2021.0301","article-title":"Ampakines Stimulate Diaphragm Activity after Spinal Cord Injury","volume":"38","author":"Rana","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ymthe.2025.06.022_bib54","series-title":"Uber die messung des Blutquantums in den Hertzvent rikeln","author":"Fick","year":"1870"},{"key":"10.1016\/j.ymthe.2025.06.022_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1542\/peds.16.1.81","article-title":"A barometric method for measuring ventilation in newborn infants","volume":"16","author":"Drorbaugh","year":"1955","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2025.06.022_bib56","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/jn.00307.2021","article-title":"Ampakine pretreatment enables a single hypoxic episode to produce phrenic motor facilitation with no added benefit of additional episodes","volume":"126","author":"Thakre","year":"2021","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.24433","article-title":"Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease","volume":"78","author":"Todd","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.022_bib58","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1039\/D2AN00710J","article-title":"Submicron 3,4-dihydroxybenzoic acid-TiO(2) composite particles for enhanced MALDI MS imaging of secondary metabolites in the root of differently aged baical skullcap","volume":"147","author":"Sun","year":"2022","journal-title":"Analyst"}],"updated-by":[{"DOI":"10.1016\/j.ymthe.2026.06.032","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}},{"DOI":"10.1016\/j.ymthe.2026.06.032","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000}}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:39:31Z","timestamp":1788406771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625004733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1525001625004733"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.022","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.10.627800","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}